Frequent gain of the human telomerase gene TERC at 3q26 in cervical adenocarcinomas. - Wikidata - awgldk - TriplyDB

Frequent gain of the human telomerase gene TERC at 3q26 in cervical adenocarcinomas.

Frequent gain of the human telomerase gene TERC at 3q26 in cervical adenocarcinomas.

http://www.wikidata.org/entity/Q36612129

about

3q26 amplification is an effective negative triage test for LSIL: a historical prospective study Impact of gene dosage on gene expression, biological processes and survival in cervical cancer: a genome-wide follow-up study.TBLR1 is a novel prognostic marker and promotes epithelial-mesenchymal transition in cervical cancer.InTERTpreting telomerase structure and function Amplified genes may be overexpressed, unchanged, or downregulated in cervical cancer cell lines.Expression of the p53 target Wig-1 is associated with HPV status and patient survival in cervical carcinoma Genomic amplification of the human telomerase gene (hTERC) associated with human papillomavirus is related to the progression of uterine cervical dysplasia to invasive cancer.The hallmarks of cancer: a long non-coding RNA point of view.The use of genetic markers to identify lung cancer in fine needle aspiration samples.Detention of HPV L1 Capsid Protein and hTERC Gene in Screening of Cervical Cancer An evaluation of SOX2 and hTERC gene amplifications as screening markers in oral and oropharyngeal squamous cell carcinomas Transducin (β)-like 1 X-linked receptor 1 promotes gastric cancer progression via the ERK1/2 pathway.Cervical FISH Testing for Triage and Support of Challenging Diagnoses: A Case Study of 2 Patients.Secondary Prevention of Cervical Cancer: ASCO Resource-Stratified Clinical Practice Guideline.Human telomerase gene amplification and high-risk human papillomavirus infection in women with cervical intra-epithelial neoplasia.Telomere Maintenance Mechanisms in Cancer.

P2860

Q28727452-D613DAF0-9218-43BC-B18D-D520D43C9F39 Q33690029-9FE4751B-3017-4687-9326-D41BFE669AC4 Q33877477-6CF8950D-4DE8-4FA9-9D1C-12B1838BAD26 Q34146318-92592982-8E0B-401A-B79E-094D54A91545 Q34193299-1E30D333-A42A-4C71-AD46-FD927B573E16 Q34472748-6AF68FC6-E2C3-4763-9844-EAECB4F04F7B Q36369632-AC86483C-B273-42E6-9620-AF4637A8DFA8 Q36391951-EC21A9B9-BC98-48D8-A1C3-B0002610A672 Q36982765-B3DF871B-C255-4CA1-9B52-334E6560D253 Q37134284-A0E71D64-1A9F-415F-9FF1-824F2A3DFBD5 Q37509141-7C665B42-EA5B-4285-B742-B1AB37DAA752 Q37736264-D3B4665B-1342-4555-8E74-3E04B0156448 Q40844769-1D634936-9FE7-4E1C-8B3D-D524BB513EAF Q43924111-A2D58480-87E7-48B3-A6D0-5078AEAFFF49 Q44323958-FD61633A-C515-4A2E-8235-E41B209E91C3 Q55443450-E01B954E-3F5F-4218-A82B-3CFBDAD143A6

P2860

Frequent gain of the human telomerase gene TERC at 3q26 in cervical adenocarcinomas.

http://www.wikidata.org/entity/Q36612129

description

2006 nî lūn-bûn

@nan

2006年の論文

@ja

2006年論文

@yue

2006年論文

@zh-hant

2006年論文

@zh-hk

2006年論文

@zh-mo

2006年論文

@zh-tw

2006年论文

@wuu

2006年论文

@zh

2006年论文

@zh-cn

name

Frequent gain of the human telomerase gene TERC at 3q26 in cervical adenocarcinomas.

@ast

Frequent gain of the human telomerase gene TERC at 3q26 in cervical adenocarcinomas.

@en

type

label

Frequent gain of the human telomerase gene TERC at 3q26 in cervical adenocarcinomas.

@ast

Frequent gain of the human telomerase gene TERC at 3q26 in cervical adenocarcinomas.

@en

prefLabel

Frequent gain of the human telomerase gene TERC at 3q26 in cervical adenocarcinomas.

@ast

Frequent gain of the human telomerase gene TERC at 3q26 in cervical adenocarcinomas.

@en

P1433

Q36612129-7F86E3FD-3131-446F-BDD4-C35C1EBD344F

P1476

Q36612129-DE8ED012-E326-4870-8210-0E5F60FD7F25

P2093

Q36612129-0758F9FE-CEBA-4EBD-BD45-703CACB7162A

Q36612129-29FB8B30-62CA-4F85-BAAC-187AEE7E634E

Q36612129-2A42DF6E-0DFB-4035-8A2C-795F157A1C10

Q36612129-2A752614-3BFC-4D80-B93C-3FB128CE9B34

Q36612129-3B943ACE-3411-4E0B-9D8A-00C1E9D019B7

Q36612129-90381917-0615-4B08-9F79-821BB944F672

Q36612129-A6188565-6B50-46E8-A587-1659642E26F8

Q36612129-D6459CC5-5989-4DEB-B5A0-3069FBF38452

Q36612129-FBD15C6D-C344-494E-BA65-79C01DB82EAF

P2860

Q36612129-01B67BED-8E57-4FF1-9D6F-330361BD2609

Q36612129-1BA7B6CD-48D6-4264-B374-28009CD0C5C2

Q36612129-27F1FDBD-6514-4FF7-923C-F831C3BD8444

Q36612129-45648041-7D9E-48D9-B2C7-186FFA504EC2

Q36612129-588B049B-DBC8-417F-9E8D-7BE2596FA877

Q36612129-61F400EA-6F92-4C9A-8924-87D1971FB637

Q36612129-6799C3F2-AA99-4775-891A-627B570B7625

Q36612129-6C7899ED-3F7D-4E1B-8FC0-5B235A7991CC

Q36612129-6CE5DC6B-D923-4A7B-983A-DAAEC0CB859A

Q36612129-6E1A4584-62F6-48BD-8FEC-520A7C19F2E4

P2888

Q36612129-07C47DCE-B58F-4364-A256-5BBCF1615995

P304

Q36612129-DDF44AF6-EC66-4121-8822-75DDE0A0C237

P31

Q36612129-10DAF946-9F99-44ED-B70C-73FB9BDE158D

P356

Q36612129-55077328-402E-40CA-B119-5BB74FEB0FAE

P407

Q36612129-24541A76-A675-4D09-9AD6-859506FD2A92

P433

Q36612129-D9DCBDA5-BEB4-445A-9658-FE2CC04DDC27

P478

Q36612129-400369F3-EEA5-4168-A0C5-402AC2454F00

P577

Q36612129-00CC61C2-5310-47FC-9E9B-BADB91AA4A3A

P5875

Q36612129-33984C1A-92A5-4591-98C8-FB18AD386CC7

P698

Q36612129-25D5D902-ECEF-4E5C-842F-70279C299891

P921

Q36612129-64064196-9C57-4EC3-BE95-BDAFFAE143AF

P932

Q36612129-93A99BEE-9083-43DF-9380-7A46FDC73030

P356

P1433

British Journal of Cancer

P1476

Frequent gain of the human telomerase gene TERC at 3q26 in cervical adenocarcinomas.

@en

P2093

A Hjerpe

http://www.w3.org/2001/XMLSchema#string

A-C Hellström

http://www.w3.org/2001/XMLSchema#string

C Larsson

http://www.w3.org/2001/XMLSchema#string

G Auer

http://www.w3.org/2001/XMLSchema#string

K Heselmeyer-Haddad

http://www.w3.org/2001/XMLSchema#string

K-L Wallin

http://www.w3.org/2001/XMLSchema#string

L E Morrison

http://www.w3.org/2001/XMLSchema#string

S Andersson

http://www.w3.org/2001/XMLSchema#string

T Ried

http://www.w3.org/2001/XMLSchema#string

P2860

Genomic amplification of the human telomerase gene (TERC) in pap smears predicts the development of cervical cancer

Human papillomavirus is a necessary cause of invasive cervical cancer worldwide

Risk factors for rapid-onset cervical cancer.

Gain of chromosome 3q defines the transition from severe dysplasia to invasive carcinoma of the uterine cervix

FIGO staging classifications and clinical practice guidelines in the management of gynecologic cancers. FIGO Committee on Gynecologic Oncology.

Papanicolaou smear sensitivity for the detection of adenocarcinoma of the cervix: a study of 49 cases.

Prevalence of human papillomavirus in cervical cancer: a worldwide perspective. International biological study on cervical cancer (IBSCC) Study Group.

Estimating the world cancer burden: Globocan 2000.

The viral etiology of cervical cancer.

Prevalence of human papillomavirus DNA in different histological subtypes of cervical adenocarcinoma.

P2888

P304

331-338

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1038/SJ.BJC.6603253

http://www.w3.org/2001/XMLSchema#string

P407

P433

3

http://www.w3.org/2001/XMLSchema#string

P478

95

http://www.w3.org/2001/XMLSchema#string

P577

2006-07-18T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

6939280

http://www.w3.org/2001/XMLSchema#string

P698

16847471

http://www.w3.org/2001/XMLSchema#string

P921

P932

2360637

http://www.w3.org/2001/XMLSchema#string